AVXL Anavex Life Sciences Corp.
Fundamentals / CIK 0001314052 / USDAnavex Life Sciences Corp. reported $120.1M in total assets and a net loss of $13.02M through September 30, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AVXL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Sep 30, 2025
-
Operating Income FY 2025-$17.37M Operating profit
-
Net Income FY 2025-$13.02M GAAP bottom line
-
Diluted EPS FY 2025-$0.00 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$118.3M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development | $37.59M | $41.84M | $43.72M | $37.92M | $32.98M | $25.23M | $22.26M | $13.34M | $10.67M | $7.25M |
| Selling, General & Admin | $13.82M | $11.04M | $12.05M | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $51.41M | $52.88M | $55.76M | $50.99M | $42.00M | -$31.09M | $29.11M | $19.33M | $15.68M | $15.59M |
| Operating Income | -$51.41M | -$52.88M | -$55.76M | -$50.99M | -$42.00M | -$31.09M | -$29.11M | -$19.33M | -$15.68M | -$15.59M |
| EBITDA | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$15.59M |
| Income Before Tax | -$46.38M | -$43.00M | -$47.50M | -$47.62M | -$37.64M | -$26.26M | -$26.21M | -$17.18M | -$13.40M | -$14.71M |
| Net Income | -$46.38M | -$43.00M | -$47.51M | -$47.98M | -$37.91M | -$26.28M | -$26.29M | -$17.25M | -$13.46M | -$14.74M |
| Basic EPS | -$0.54 | -$0.52 | -$0.60 | -$0.62 | -$0.54 | -$0.45 | -$0.54 | -$0.39 | -$0.33 | -$0.42 |
| Diluted EPS | -$0.54 | -$0.52 | -$0.60 | -$0.62 | -$0.54 | -$0.45 | -$0.54 | -$0.39 | -$0.33 | -$0.42 |
| Basic Shares Outstanding | 85.3M | 83.5M | 79.8M | 76.9M | 69.8M | 58.2M | 48.9M | 44.7M | 40.8M | 35.2M |
| Diluted Shares Outstanding | 85.3M | 83.5M | 79.8M | 76.9M | 69.8M | 58.2M | 48.9M | 44.7M | 40.8M | 35.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | -- | $4.19M | $4.66M | $7.29M | $9.96M | $9.89M | $10.45M | $11.61M |
| Selling, General & Admin | $2.03M | $2.29M | $2.13M | $3.55M | $4.50M | $2.62M | $3.15M | -- |
| Total Operating Expenses | -$6.74M | $6.48M | $6.78M | $10.84M | $14.46M | $12.51M | $13.59M | $14.27M |
| Operating Income | $6.74M | -$6.48M | -$6.78M | -$10.84M | -$14.46M | -$12.51M | -$13.59M | -$14.27M |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -- | -$11.74M |
| Income Tax Expense | $0 | $0 | $18K | -- | -- | -- | -- | -- |
| Net Income | $7.82M | -$5.34M | -$5.68M | -$9.83M | -$13.24M | -$11.20M | -$12.11M | -$11.62M |
| Basic EPS | $0.08 | -$0.06 | -$0.06 | -- | -$0.16 | -$0.13 | -$0.14 | -- |
| Diluted EPS | $0.08 | -$0.06 | -$0.06 | -- | -$0.16 | -$0.13 | -$0.14 | -- |
| Basic Shares Outstanding | 92.70B | 92.7M | 89.0M | -- | 85.38B | 85.1M | 84.8M | -- |
| Diluted Shares Outstanding | 92.90B | 92.7M | 89.0M | -- | 85.38B | 85.1M | 84.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $102.6M | $132.2M | $151.0M | $149.2M | $152.1M | $29.25M | $22.19M | $22.93M | $27.44M | $9.19M |
| Cash & Short-Term Investments | $102.6M | $132.2M | $151.0M | $149.2M | $152.1M | $29.25M | $22.19M | $22.93M | $27.44M | $9.19M |
| Total Current Assets | -- | -- | -- | -- | -- | -- | $25.33M | $26.05M | $27.79M | $9.45M |
| Total Non-Current Assets | -- | -- | -- | -- | -- | -- | $0 | $154K | $52K | $52K |
| Total Assets | $103.8M | $135.6M | $154.4M | $152.7M | $161.6M | $34.54M | $25.33M | $26.21M | $27.84M | $9.50M |
| Accounts Payable | $4.25M | $9.63M | $4.32M | $3.83M | $4.74M | $3.99M | $3.52M | $2.96M | -- | -- |
| Total Current Liabilities | -- | -- | -- | -- | $10.80M | $7.31M | $5.04M | $3.88M | $3.58M | $3.19M |
| Total Non-Current Liabilities | -- | -- | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $8.95M | $15.30M | $12.53M | $10.21M | $10.80M | $7.31M | $5.04M | $3.88M | $3.58M | $3.19M |
| Common Stock | $87K | $85K | $82K | $78K | $76K | $62K | $53K | $46K | $43K | $36K |
| Retained Earnings | -$382.4M | -$336.1M | -$293.1M | -$245.6M | -$197.6M | -$159.7M | -$133.4M | -$107.1M | -$91.48M | -$78.02M |
| Total Stockholders' Equity | $94.87M | $120.3M | $141.9M | $142.5M | $150.8M | $27.24M | $20.29M | $22.32M | $25.88M | $6.31M |
| Total Equity | $94.87M | $120.3M | $141.9M | $142.5M | $150.8M | $27.24M | $20.29M | $22.32M | $25.88M | $6.31M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $118.3M | $127.4M | $131.7M | $102.6M | $101.2M | $115.8M | $120.8M | $132.2M |
| Cash & Short-Term Investments | $118.3M | $127.4M | $131.7M | $102.6M | $101.2M | $115.8M | $120.8M | $132.2M |
| Total Assets | $120.1M | $128.8M | $133.0M | $103.8M | $102.4M | $117.1M | $124.0M | $135.6M |
| Accounts Payable | $3.66M | $2.52M | $2.64M | $4.25M | $6.74M | $7.00M | $4.57M | $9.63M |
| Total Liabilities | $7.69M | $7.06M | $6.37M | $8.95M | $11.47M | $17.38M | $13.13M | $15.30M |
| Common Stock | $93K | $93K | $93K | $87K | $85K | $85K | $85K | $85K |
| Retained Earnings | -$385.6M | -$393.5M | -$388.1M | -$382.4M | -$372.6M | -$359.4M | -$348.2M | -$336.1M |
| Total Stockholders' Equity | $112.4M | $121.7M | $126.6M | $94.87M | $90.96M | $99.76M | $110.9M | $120.3M |
| Total Equity | $112.4M | $121.7M | $126.6M | $94.87M | $90.96M | $99.76M | $110.9M | $120.3M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$46.38M | -$43.00M | -$47.51M | -$47.98M | -$37.91M | -$26.28M | -$26.29M | -$17.25M | -$13.46M | -$14.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | $1.3K |
| Stock-Based Compensation | $11.55M | $9.44M | $16.37M | $18.38M | $8.23M | $4.88M | $6.43M | $5.52M | $4.14M | $5.06M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | -$30K | $54K | -$2.5K |
| Change in Payables | -$5.38M | $5.30M | $497K | -$914K | $751K | $466K | $684K | $38K | -- | -- |
| Operating Cash Flow | -$39.04M | -$30.81M | -$27.79M | -$24.24M | -$30.38M | -$21.29M | -$18.53M | -$12.58M | -$9.02M | -$9.24M |
| Common Stock Issued | -- | $11.28M | $27.88M | $20.98M | $153.2M | $28.75M | $17.83M | $8.17M | $27.27M | $3.17M |
| Financing Cash Flow | $9.43M | $11.97M | $29.65M | $21.29M | $153.2M | $28.35M | $17.78M | $8.07M | $27.27M | $3.13M |
| Net Change in Cash | -$29.61M | -$18.84M | $1.87M | -$2.95M | $122.9M | $7.06M | -$745K | -- | -- | -- |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $7.82M | -$5.34M | -$5.68M | -$9.83M | -$13.24M | -$11.20M | -$12.11M | -$11.62M |
| Stock-Based Compensation | -$17.08M | $314K | $1.11M | $3.72M | $4.32M | $1.45M | $2.06M | $2.01M |
| Change in Payables | $1.14M | -$119K | -$1.61M | -$2.49M | $2.01M | $167K | -$5.06M | $6.07M |
| Operating Cash Flow | -$9.10M | -$4.44M | -$7.15M | -$8.60M | -$12.46M | -$5.86M | -$12.12M | -$6.66M |
| Financing Cash Flow | $0 | $113K | $36.32M | $10.02M | -$2.14M | $852K | $708K | $89K |
| Net Change in Cash | -$9.10M | -$4.33M | $29.17M | $1.41M | -$14.61M | -$5.00M | -$11.41M | -$6.57M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -48.9% | -35.8% | -33.5% | -33.7% | -25.1% | -96.5% | -129.6% | -77.3% | -52.0% | -233.6% |
| Return on Assets (ROA) | -44.7% | -31.7% | -30.8% | -31.4% | -23.5% | -76.1% | -103.8% | -65.8% | -48.4% | -155.1% |
| Current Ratio | -- | -- | -- | -- | -- | -- | 5.03x | 6.71x | 7.75x | 2.96x |
| Quick Ratio | -- | -- | -- | -- | 14.09x | 4.00x | 4.40x | 5.90x | 7.66x | 2.88x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -11.6% | -28.0% | -31.5% | -48.9% | -53.0% | -47.3% | -41.9% | -35.8% |
| Return on Assets (ROA) | -10.8% | -26.5% | -30.0% | -44.7% | -47.0% | -40.2% | -37.5% | -31.7% |